Material Agreements

Sky Harbour Group Corp entered into SJC Lease with City of San Jose (effective 2024-03-23).

“On March 23, 2024, Sky Harbour Group Corporation (the “Company”), through a wholly-owned subsidiary of the Company, entered into a ground lease agreement (the “SJC Lease”) at San Jose Mineta International Airport (“SJC”) with the City of San Jose.”

Viveon Health Acquisition Corp. entered into Non-Redemption Agreement with Viveon Health LLC (the Sponsor) and certain institutional investors named therein (effective 2024-03-27).

“On March 27, 2024, (the Company , entered into a non-redemption agreement (the “ Non-Redemption Agreement ”) with Viveon Health LLC (the “ Sponsor ”) and certain institutional investors named therein (the “ Investors ”).”

Clever Leaves Holdings Inc. entered into "Purchase Agreement" with KAC Investments LLC valued at $8.02 million (effective 2024-03-21).

“On March 21, 2024 (the “Closing Date”), Clever Leaves Holdings, Inc. (the “Company”) and NS US Holdings, Inc. (the “Seller”), which is a wholly owned subsidiary of the Company, entered into a Stock Purchase Agreement (the “Purchase Agreement”) with KAC Investments LLC (the “Buyer”), pursuant to which the Company sold its non-cannabinoid business segment (the “Sale Transaction”), which is comprised of the Company’s wholly owned subsidiary Herbal Brands, Inc. (“HBI”, and together with the Company and the Seller, collectively the “Seller Parties”).”

Fresh2 Group Ltd entered into Asset Purchase Agreement with YBB TECHNOLOGY INC. valued at aggregate purchase price consists of (i) 112,500,000 Class A ordinary shares of the Company valued a (effective 2024-03-22).

“On March 22, 2024, Fresh2 Group Limited (the “Company”) and its subsidiary, Fresh2 Information Inc, entered into an asset purchase agreement with YBB TECHNOLOGY INC., a New Jersey corporation providing Asian food and grocery delivery services as well as operating a food wholesale business (the “Seller”), to acquire the Seller’s food wholesale business, including inventories, account receivables, account payables, equipment, technology platform, intellectual property, books and records, licenses and permits, and other assets related to such business. The aggregate purchase price consists of (i) 112,500,000 Class A ordinary shares of the Company valued at $4,500,000, and (ii) $150,000 in cash.”

Varex Imaging Corp terminated Senior Secured Asset-Based Revolving Credit Agreement with Bank of America N.A. valued at Terminated (effective 2024-03-26).

“Simultaneous with its entry into the Credit Facility, the Company terminated its senior secured asset-based revolving credit agreement, dated as of September 30, 2020, with Bank of America N.A., as administrative and collateral agent, and the lenders named therein, providing for the asset-backed lending facility (the “ Existing Credit Facility ”).”

Varex Imaging Corp entered into Senior Secured Revolving Credit Agreement with Zions Bancorporation, N.A. DBA Zions First National Bank valued at $155 million (effective 2024-03-26).

“On March 26, 2024 , Varex Imaging Corporation (the “ Company ”), Varex Imaging West, LLC (“ VI West ”) and Varex Imaging Deutschland AG (the “ German Borrower ” and together with the Company and VI West, the “ Borrowers ”) and certain guarantors party thereto (the “ Guarantors ”) entered into a senior secured revolving credit agreement, dated as of March 26, 2024 (the “ Credit Agreement ”) with Zions Bancorporation, N.A. DBA Zions First National Bank (“ Zions ”), as administrative and collateral agent, the lenders named therein, the issuing banks named therein, and Zions, as lead arranger and bookrunner, providing for a senior secured revolving credit facility of up to $155 million (the “ Credit Facility ”).”

AMERICAN REBEL HOLDINGS INC entered into Revenue Interest Purchase Agreement with an individual accredited investor valued at $100,000 (effective 2024-03-22).

“On March 22, 2024, the Registrant entered into a Revenue Interest Purchase Agreement (the " Revenue Interest Purchase Agreement ") with an individual accredited investor, pursuant to which the investor purchased a revenue interest from the Registrant for $100,000.”

Avalon GloboCare Corp. entered into Mortgage and Security Agreement dated March 27, 2024 (Mast Hill Mortgage) with Mast Hill Fund L.P. valued at $2,200,000.00 combined principal sum (effective 2024-03-27).

“On March 27, 2024, Avalon Globocare Corp. (the "Company") entered into a Mortgage and Security Agreement (the "Mast Hill Mortgage") with Mast Hill Fund L.P. ("Mast Hill") to secure the payment performance and obligation under certain follow-up financing agreements described below.”

Hilton Worldwide Holdings Inc. entered into Indenture with Wilmington Trust, National Association valued at $550 million aggregate principal amount of 5.875% Senior Notes due 2029 and $450 million aggregate p (effective 2024-03-26).

“On March 26, 2024, Hilton Domestic Operating Company Inc. (the “Issuer”), an indirect subsidiary of Hilton Worldwide Holdings Inc. (the “Company”), issued and sold $550 million aggregate principal amount of 5.875% Senior Notes due 2029 (the “2029 Notes”) and $450 million aggregate principal amount of 6.125% Senior Notes due 2032 (the “2032 Notes” and, together with the 2029 Notes, the “Notes”), in each case, under an Indenture, dated as of March 26, 2024 (the “Indenture”), by and among the Issuer, the Company, as a guarantor, the other guarantors party thereto and Wilmington Trust, National Association, as trustee (in such capacity, the “Trustee”).”

Aramark amended Amendment No. 14 with the financial institutions party thereto and JPMorgan Chase Bank, N.A. valued at an amount equal to $730,458,023.44 due in April 2028 and an amount equal to $1,094,500,000.00 due in (effective 2024-03-27).

“On March 27, 2024 (the “ Closing Date ”), Aramark Services, Inc. (the “ Company ”), an indirect wholly-owned subsidiary of Aramark (“ Aramark ” or “ Parent ”), Aramark Intermediate HoldCo Corporation (“ Holdings ”) and certain wholly-owned domestic subsidiaries of the Company entered into Amendment No. 14 (the “ Amendment ”) with the financial institutions party thereto and JPMorgan Chase Bank, N.A. as administrative agent for the Lenders (as defined below) and collateral agent for the secured parties thereunder to the Credit Agreement (as amended by the Amendment, the “ Credit Agreement ”), dated March 28, 2017, among the Company, Holdings, certain other borrowers party thereto and certain wholly-owned domestic subsidiaries of the Company, the financial institutions from time to time party thereto (including the financial institutions party to the Amendment, the “Lenders”), the issuing banks named therein and JPMorgan Chase Bank, N.A., as administrative agent for the Lenders and colla”

STARWOOD PROPERTY TRUST, INC. entered into Indenture and Senior Notes due 2029 with The Bank of New York Mellon valued at $600,000,000 aggregate principal amount of 7.250% unsecured senior notes due 2029 (effective 2024-03-27).

“On March 27, 2024, Starwood Property Trust, Inc., a Maryland corporation (the “Company”), closed its private offering of $600 million aggregate principal amount of its 7.250% unsecured senior notes due 2029 (the “Notes”), which priced on March 13, 2024.”

CASTLE BIOSCIENCES INC entered into Loan and Security Agreement with Silicon Valley Bank, a division of First-Citizens Bank & Trust Company valued at $10.0 million aggregate principal amount of term loans (effective 2024-03-26).

“On March 26, 2024 (the “Closing Date”), Castle Biosciences, Inc., a Delaware corporation (the “Company”), entered into a Loan and Security Agreement (the “Loan Agreement”), by and between the Company, its wholly owned subsidiary, Castle Narnia Real Estate Holding 1, LLC (“Narnia”) and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company (the “Lender”).”

Data Storage Corp entered into Sublease Agreement with Sentinel Benefits Group, LLC and Sentinel Benefits Group, Inc. valued at $143,173.00 (effective 2024-01-17).

“Data Storage Corporation (the “Company”) entered into Sublease Agreement, dated as of January 17, 2024, with Sentinel Benefits Group, LLC, a Delaware limited liability company, and Sentinel Benefits Group, Inc., a Massachusetts corporation (the “Sublease Agreement”), to sublease certain office space in Melville, NY, which Sublease Agreement became effective March 25, 2024 upon receipt of the consent to the Sublease Agreement from the landlord of the subject property.”

LendingTree, Inc. entered into facility with Apollo Funds valued at up to $175 million.

“funds managed by Apollo affiliates ("Apollo Funds") have agreed to commit up to $175 million of financing for LendingTree in the form of a first lien term loan facility (the "facility")”

Iridium Communications Inc. amended Amendment No. 1 (the "Amendment") to the Amended and Restated Credit Agreement with various lenders and Deutsche Bank AG New York Branch, as Administrative Agent and Collateral Agent; Deutsche Bank Securities Inc., Barclays Bank PLC, and Wells Fargo Securities, LLC, as Joint Lead Arrangers and Bookrunners valued at $125 million (effective 2024-03-25).

“On March 25, 2024, Iridium Satellite LLC (“Satellite”), the Registrant’s principal operating subsidiary, as the borrower, entered into Amendment No. 1 (the “Amendment”) to its existing Amended and Restated Credit Agreement, dated as of September 20, 2023, with Iridium Holdings LLC (“Holdings”), as guarantor; solely with respect to Section 10.12 thereof, the Registrant; various lenders; and Deutsche Bank AG New York Branch, as Administrative Agent and Collateral Agent; with Deutsche Bank Securities Inc., Barclays Bank PLC, and Wells Fargo Securities, LLC , as Joint Lead Arrangers and Bookrunners (the “Credit Agreement”) .”

Value Exchange International, Inc. entered into Loan Agreement valued at One Million U.S. Dollars and No Cents (USD$1,000,000.00) (effective 2024-03-21).

“f the Loan Agreement. As such, the Board also concluded that in respect of the nine directors of the Company: Company directors Chan”

bowmo, Inc. entered into Merger Agreement with OWNverse, LLC (effective 2024-03-22).

“On March 22, 2024, bowmo, Inc. (the “Company”) entered into a Plan and Agreement of Merger (the “Merger Agreement”) with OWNverse, LLC, a Delaware limited liability company (“OWNverse”)”

Consolidated Communications Holdings, Inc. entered into Term Loan Agreement with Searchlight CVL AGG, L.P. valued at aggregate amount of $80.0 million (effective 2024-03-21).

“On March 21, 2024, Consolidated Communications Holdings, Inc. (the “Company”), its wholly owned subsidiary, Consolidated Communications, Inc. (“CCI”), as borrower, certain other wholly owned subsidiaries of CCI, as guarantors (the “Guarantors”), and Searchlight CVL AGG, L.P., as lender (the “Lender”) entered into that certain Term Loan Agreement (the “Term Loan Agreement”), which consists of delayed draw term loans in the aggregate amount of $80.0 million (the “Loan”).”

SCIENTIFIC ENERGY, INC amended Amended and Restated Agreement for Purchase of Graphite Ore with Madagascar Graphite Limited (effective 2024-03-22).

“As previously reported, on January 18, 2024, Scientific Energy, Inc., a Utah corporation (the “Company”) entered into a Base Agreement for Purchase of Graphite Ore (the “Original Agreement”) with Madagascar Graphite Limited (the “Supplier”). On March 22, 2024, the Original Agreement was amended and restated by the parties.”

LIQUIDITY SERVICES INC amended Second Amendment to Credit Agreement with Wells Fargo Bank, National Association (effective 2024-03-27).

“On March 27, 2024, Liquidity Services, Inc. (the “Company”) and Wells Fargo Bank, National Association (the “Lender”) entered into the Second Amendment to Credit Agreement, which amends that certain Credit Agreement by and between the Company and the Lender, dated February 10, 2022 (the “Credit Agreement”) by extending the term of the Credit Agreement from March 31, 2025 to March 31, 2026.”

COMPASS MINERALS INTERNATIONAL INC amended Amendment with JPMorgan Chase Bank, N.A., as administrative agent and the lenders (effective 2024-03-27).

“On March 27, 2024, Compass Minerals International, Inc. (the “Company”) entered into an amendment no. 1 (the “Amendment”) to the credit agreement dated as of April 20, 2016”

Big Digital Energy, Inc. amended Customer Service Addendum with Consensus Technology Group LLC (effective 2024-03-25).

“On March 25, 2024, Mawson Infrastructure Group, Inc (“Mawson” or “the Company”) signed a customer service addendum to its previous Customer Service Framework Agreement (“Customer Agreement”) with Consensus Technology Group LLC (“Consensus”) that expanded its co-location services business by approximately an additional 5,880 miners or approximately an additional 20 MW.”

AppTech Payments Corp. entered into Underwriting Agreement with EF Hutton LLC valued at approximately $1.8 million (effective 2024-03-26).

“On March 26, 2024, AppTech Payments Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with EF Hutton LLC, as representative of the several underwriters named in Schedule 1 thereto (the “Underwriters”), relating to the public offering of 2,000,000 shares of common stock, par value $0.001 per share (“Common Stock”), at a purchase price per share to the public of $1.00 (the “Offering Price”).”

SONIC AUTOMOTIVE INC amended Fifth Amendment to Credit Agreement with PNC Bank, National Association (effective 2024-03-22).

“On March 22, 2024, Sonic Automotive, Inc. (the “Company”) and certain of its subsidiaries entered into the Fifth Amendment to Credit Agreement (the “Amendment”) with PNC Bank, National Association (“PNC”), as administrative agent, and the other financial institutions party thereto.”

Golden Minerals Co terminated Earn-In Agreement with Barrick Gold Corporation valued at $10 million in work expenditures (effective 2024-04-20).

“On March 21, 2024, Golden Minerals Company (the "Company") received written notice from Barrick Gold Corporation ("Barrick"), notifying the Company of Barrick's election to terminate the Earn-In Agreement, dated as of April 9, 2020, by and among the Company, several of the Company's directly and indirectly wholly owned subsidiaries, and Barrick (the "Earn-In Agreement") under which Barrick acquired an option to earn a 70% interest in the Company's El Quevar project located in the Salta Province of Argentina.”

PURE BIOSCIENCE, INC. entered into Note Purchase Agreement with certain accredited investors valued at $500,000 (effective 2024-03-22).

“On March 22, 2024, Pure Bioscience, Inc. (the “Company”) entered into a Note Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (“Lenders”) pursuant to which the Company issued the Lenders convertible promissory notes (the “Notes”, collectively with the Note Purchase Agreement, the “Notes Documents”) with an aggregate principal balance of $500,000 (the “Private Placement”).”

Hyperscale Data, Inc. amended the Amendment valued at $75,000,000.00 (effective 2024-03-25).

“On March 25, 2024, the Company and the Purchaser entered into the Amendment, pursuant to which the total amount of the Financing was increased to $75,000,000.00”

Hyperscale Data, Inc. entered into Agreement valued at up to $50,000,000.00 (effective 2023-11-06).

“On November 6, 2023 (the “ Execution Date ”), the Company entered into the Agreement with the Purchaser, pursuant to which the Company agreed to sell to the Purchaser up to 50,000 shares of Series C convertible preferred stock (the “ Series C Convertible Preferred Stock ”), and Series C Warrants to purchase shares of Common Stock, in one or more closings, for a total purchase price of up to $50,000,000.00”

Rennova Health, Inc. amended Series B Warrants with certain institutional holders (effective 2024-03-20).

“On March 20, 2024, Rennova Health, Inc. (the “Company”) and certain institutional holders agreed that, with respect to Series B Warrants (originally issued on March 21, 2017), to acquire 101,350,000,000 shares of common stock, the termination date of such warrants would be extended from March 21, 2024 to December 31, 2025”

ACURA PHARMACEUTICALS, INC amended Amendment #2 with Abuse Deterrent Pharma, LLC (effective 2024-03-15).

“On March 25, 2024, Acura Pharmaceuticals, Inc. (“we” “Acura” or the “Company”), received the executed agreement to further amend the November 10, 2022 Amended, Consolidated and Restated Secured Promissory Note (the “Note”) with Abuse Deterrent Pharma, LLC (“AD Pharma”). Amendment #2 has an effective date of March 15, 2024 and changes the maturity date of the Note from March 31, 2024 to June 30, 2024, at which time all principal and interest is due. As of March 15, 2024, the Note’s principal balance was $5,419,279, bears interest at 5.25%, and had an accrued interest balance of approximately $265,000.”

ACURA PHARMACEUTICALS, INC amended Amended Agreement with Abuse Deterrent Pharma, LLC (effective 2024-03-25).

“On March 25, 2024, Acura Pharmaceuticals, Inc. (“we” “Acura” or the “Company”), received the executed agreement to further amend the June 28, 2019 License, Development and Commercialization Agreement (“Agreement”) with Abuse Deterrent Pharma, LLC (“AD Pharma”), for the development of LTX-03 (hydrocodone bitartrate with acetaminophen) immediate-release tablets utilizing Acura’s patented LIMITx technology which addresses the consequences of excess oral administration of opioid tablets, the most prevalent route of opioid overdose and abuse. The amendment to the Agreement extends the FDA’s acceptance date of a New Drug Application (“NDA”) for LTX-03 to June 30, 2024 (“NDA Acceptance Date”) (“Amended Agreement”).”

Black Hawk Acquisition Corp amended Letter Agreement with EF Hutton LLC (effective 2024-03-25).

“on March 25, 2024, the Company entered into a letter agreement (the “Letter Agreement”) with EF Hutton LLC, as representative of the several underwriters named on Schedule A of the Underwriting Agreement, to amend the Underwriting Agreement”

Black Hawk Acquisition Corp amended Subscription Agreement with the Sponsor (effective 2024-03-20).

“Subscription Agreement, dated October 16, 2023, as amended, by and between the Company and the Sponsor on November 13, 2023 and March 20, 2024”

Black Hawk Acquisition Corp entered into Registration Rights Agreement with the Sponsor (effective 2024-03-20).

“● Registration Rights Agreement, dated March 20, 2024, by and between the Company and the Sponsor, a copy of which is filed as Exhibit”

Black Hawk Acquisition Corp entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company, as trustee (effective 2024-03-20).

“Investment Management Trust Agreement, dated March 20, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as trustee”

Black Hawk Acquisition Corp entered into Underwriting Agreement with EF Hutton LLC (effective 2024-03-20).

“Underwriting Agreement, dated March 20, 2024, by and between the Company and EF Hutton LLC (the “Underwriting Agreement”)”

MGO Global Inc. entered into Deed of Novation, Assignment and Assumption with Centric Brands LLC valued at $2,000,000 (effective 2024-03-21).

“On March 21, 2024, MGO LLC, Centric and LMM signed a Deed of Novation, Assignment and Assumption (the “Deed”) providing for MGO LLC to assign all of its rights and obligations under the License Agreement to Centric, and the agreement by Centric to assume all of MGO LLC’s rights and obligations in respect of the License Agreement with effect on and from March 21, 2024.”

MAIA Biotechnology, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at approximately $1.33 million (effective 2024-03-25).

“On March 25, 2024, MAIA Biotechnology, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain accredited investors (the “ Investors ”) for the issuance and sale in a private placement (the “ Private Placement ”) of (i) 578,643 shares (the “ Shares ”) of the Company’s common stock, par value $0.0001 per share (“ Common Stock ”), and (ii) warrants (the “ Warrants ”) to purchase up to 578,643 shares of Common Stock, at a price per share of $2.295, for an aggregate purchase price of approximately $1.33 million.”

HCM Acquisition Corp terminated Second Amended and Restated Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2024-01-19).

“the Second Amended and Restated Investment Management Trust Agreement, dated January 19, 2024, by and between HCM and Continental Stock Transfer & Trust Company, as trustee, terminated pursuant to its terms”

Trump Media & Technology Group Corp. entered into Disputed Shares Escrow Agreements with Odyssey Transfer and Trust Company valued at 3,579,480 shares of TMTG Common Stock (ARC); 1,087,552 shares of TMTG Common Stock (Non-ARC Class B) (effective 2024-03-21).

“on March 21, 2024, Digital World entered into two escrow agreements with Odyssey Transfer and Trust Company, a Minnesota corporation, as escrow agent (the “ Escrow Agent ”), as follows: (i) an escrow agreement for the benefit of ARC (the “ ARC Escrow Agreement ”), pursuant to which TMTG deposited into escrow 3,579,480 shares of TMTG Common Stock, and (ii) an escrow agreement for the benefit of the holders of Digital World Class B Common Stock other than the Sponsor (the “ Non-ARC Class B Shareholders Escrow Agreement, ” and together with the ARC Escrow Agreement, the “ Disputed Shares Escrow Agreements ”), pursuant to which TMTG deposited into escrow 1,087,552 shares of TMTG Common Stock, which amounts represent the difference between the actual conversion ratio, determined by Digital World’s board of directors upon closing of the Business Combination (which was determined to be 1.348:1), and a conversion ratio of 2.00.”

Longevity Health Holdings, Inc. entered into Membership Interest Purchase Agreement with Burns Ventures, LLC, H. Rodney Burns, AXO XP, LLC, and Protein Genomics, LLC (effective 2024-03-20).

“On March 20, 2024, Carmell Corporation, a Delaware corporation (the “Company”), and Axolotl Biologix, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (“AxoBio”), entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”), with the stockholders of AxoBio immediately before the Merger (as defined below), including Burns Ventures, LLC, a Texas limited liability company (“BVLLC”), H. Rodney Burns, an individual resident of Texas (“Burns”), AXO XP, LLC, an Arizona limited liability company (“AXPLLC”), and Protein Genomics, LLC, a Delaware corporation (“PGEN” and together with BVLLC, Burns, and AXPLLC, collectively, the “Buyers” and each, a “Buyer”), providing for, upon the terms and subject to the conditions set forth therein, the sale by the Company of all outstanding limited liability company interests of AxoBio to the Buyers (the “Sale”) for the consideration described in detail below.”

ARKO Corp. entered into Master Supply Agreement with Core-Mark International, Inc. (effective 2024-02-19).

“On March 21, 2024, GPM Investments, LLC, a Delaware limited liability company, a subsidiary of ARKO Corp., a Delaware corporation (the “Company”), entered into a Master Supply Agreement (the “Supply Agreement”), effective as of February 19, 2024 (the “Effective Date”), with Core-Mark International, Inc. (“Core-Mark”), a national wholesaler, which is the Company’s primary grocer serving substantially all of the Company’s retail locations.”

Hillman Solutions Corp. amended Second Term Loan Amendment with Jefferies Finance LLC (effective 2024-03-26).

“On March 26, 2024, Hillman Solutions Corp.’s (the “ Company ”) wholly‐owned subsidiaries, The Hillman Companies, Inc., (“ Holdings ”) and The Hillman Group, Inc. (the “ Borrower ”), entered into Amendment No. 2 to the existing term loan credit agreement (the “ Second Term Loan Amendment ”) with Jefferies Finance LLC, as administrative agent, to make certain changes to reduce the Applicable Rate of the term loan by 25 bps and eliminate the Term SOFR Adjustment”

ShiftPixy, Inc. entered into Asset Purchase Agreement with Neozene, Inc. Principals and affiliated Seller Entities valued at $16,500,000 (effective 2024-03-22).

“On March 22, 2024, ShiftPixy, Inc. (the “Company”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with the owners of Neozene, Inc. (the “Principals”) and affiliated Seller Entities (collectively the “Sellers”) pursuant to which the Company will be acquiring substantially all of the assets of the Sellers”

Datavault AI Inc. entered into Warrant Amendment Agreement with certain holders (effective 2024-03-26).

“WiSA Technologies, Inc., a Delaware corporation (the “Company”), entered into a warrant amendment agreement (the “Warrant Amendment Agreement”), with certain holders (the “Holders”) of (i) certain common stock purchase warrants”

GD Culture Group Ltd entered into Placement Agency Agreement with Univest Securities, LLC valued at 810,277 shares of common stock at $1.144 per share; net proceeds approx. $830,000; placement agent f (effective 2024-03-22).

“On or about March 22, 2024, GD Culture Group Limited (the “Company”, “we”, “us” or “our”) entered into a placement agency agreement (the “Placement Agency Agreement”), with Univest Securities, LLC (the “Placement Agent” or “Univest”).”

BIOTRICITY INC. entered into Purchase Agreement with an institutional investor (effective 2024-03-25).

“On March 25, 2024, Biotricity Inc. (the “Company”) entered into a security purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”) for the issuance and sale, in a private placement offering (the “Private Placement”), of 110 shares of the Company’s Series B Convertible Preferred Stock, $0.001 par value (the “Series B Preferred Stock”), at a purchase price of $9,090.91 per share of Series B Convertible Preferred Stock, for gross proceeds of $1,000,000.”

U.S. SILICA HOLDINGS, INC. amended Amendment No. 1 to Credit Agreement with BNP Paribas valued at repricing transaction reduces margins by 75 bps, includes $25 million repayment (effective 2024-03-25).

“On March 25, 2024, U.S. Silica Holdings, Inc. (the “Company”), through its subsidiaries, USS Holdings, Inc. (“Parent”), as guarantor, U.S. Silica Company (“U.S. Silica”), as borrower, and certain of U.S. Silica’s subsidiaries, as additional guarantors, entered into Amendment No. 1 to Credit Agreement (the “Repricing Amendment”), dated as of March 25, 2024, with BNP Paribas, as administrative agent (the “Agent”) for the lenders consenting to the Repricing Amendment, which amends certain terms in that certain Fourth Amended and Restated Credit Agreement, dated as of March 23, 2023 (the “Credit Agreement”), by and among Parent, U.S. Silica, certain of U.S. Silica’s subsidiaries party thereto, the lenders party thereto and the Agent.”

KALA BIO, Inc. entered into Securities Purchase Agreement with certain institutional investors named therein valued at aggregate gross proceeds of approximately $8.6 million (effective 2024-03-25).

“On March 25, 2024, KALA BIO, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain institutional investors named therein (the “Purchasers”), pursuant to which the Company agreed to issue and sell, in a private placement priced at-the-market under Nasdaq rules, shares (the “Preferred Shares”) of Series G Convertible Non-Redeemable Preferred Stock, par value $0.001 per share, of the Company (the “Series G Preferred Stock”), for aggregate gross proceeds of approximately $8.6 million (the “Private Placement”).”

Immunome Inc. entered into BMS License with Bristol-Myers Squibb Company valued at up to approximately $142 million.

“In November 2017, Ayala entered into a License Agreement with Bristol-Myers Squibb Company (“BMS”), as amended by that certain First Amendment to License Agreement dated as of May 4, 2020 (the “BMS License”).”